Filter Results:
(176)
Show Results For
- All HBS Web
(176)
- People (1)
- News (50)
- Research (84)
- Events (3)
- Multimedia (8)
- Faculty Publications (52)
Show Results For
- All HBS Web
(176)
- People (1)
- News (50)
- Research (84)
- Events (3)
- Multimedia (8)
- Faculty Publications (52)
- 23 Mar 2016
- News
Curing Parkinson’s Disease
HBS alumni Jonathan Solomon and Hampus Hillerstrom (both MBA 2007) play an important role in Jon Palfreman’s recent book Brain Storms: The Race to Unlock the Mysteries of Parkinson’s Disease. As the cofounders of NeuroPhage Pharmaceuticals, the pair is working to... View Details
- Career Coach
Alan Braly
Alan (MBA ’10; SM, MIT ’11; BS, JHU ’02) has ~20 years of life sciences experience across a variety of therapeutic areas, roles, and sectors, working in product management, strategy, innovation, and product development in biotech, medical... View Details
- Profile
Arjun Goyal
the possibilities, Arjun sought “a better understanding of how to go from lab work to medical product” by taking an internship (after fulfilling his medical residency in Sydney, Australia) with Celtic Therapeutics in New York City. One of... View Details
- 15 Sep 2020
- Blog Post
One Month into the New MS/MBA Biotech
perfectly for our August course. Initially, we planned to offer Lab Essentials as a hands-on lab course to immerse everyone back into the science, but with the coronavirus pandemic hitting globally, we realized that we had a unique opportunity to discuss the basic... View Details
- 23 Mar 2016
- News
Building a Biotech Business from Farmed Fish
Charlton Ames (MBA 1970) is chairman and vice president of business development for Sea Run Holdings, a virtual firm in Maine that develops innovative biologics and therapeutics from the blood of farmed salmon. In this video he explains... View Details
- 01 Dec 2019
- News
The Race Against Resistance
with the rise of antibiotic-resistant superbugs. “We are approaching a cliff,” says Anna Diaz Triola (MBA 2000), vice president of marketing at Summit Therapeutics in Cambridge, Massachusetts, which is part of a cohort of small pharma... View Details
Keywords: Lisa Scanlon Mogolov
Arjun Goyal
Medicines (NASDAQ:FIXX), Pionyr Immunotherapeutics (acquired by Gilead), Peloton Therapeutics (acquired by Merck & Co.), and Asklepios Bio (acquired by Bayer). Before co-founding Vida Ventures in 2017, Arjun was a life sciences... View Details
Keywords: Finance
Arjun Goyal
a director on the boards of Scorpion Therapeutics, Quanta Therapeutics, Affini-T and Centessa Pharmaceuticals (NASDAQ: CNTA) and has played key roles in Vida Venture’s investments in Homology Medicines (NASDAQ:FIXX), Pionyr Immunotherapeutics (acquired by Gilead),... View Details
- Fast Answer
Pharmaceuticals: Pipeline
Profiles cover detailed information such as alternative names, therapeutic uses, FDA actions and licensing changes, companies associated with development of the drug, etc. To begin a search, use the function BI PHRM DEX, select... View Details
- 20 Jul 2017
- News
Life Lab Nurtures Early Stage Startup Day Zero Diagnostics
ability to treat patients with targeted therapeutics within hours of being admitted to the hospital—on Day Zero. The five-member founding team includes two MD PhDs who specialize in infectious disease (Doug Kwon) and clinical pathology... View Details
- 03 Dec 2001
- Research & Ideas
Healthcare Conference Looks At Ailing Industry
medicine is that most therapeutics were directed at symptoms, not causes.—Eric S. Lander With that in mind, about 200 HBS alumni working in the healthcare field converged in mid-November at the Charles Hotel in Cambridge to learn from... View Details
- 01 Dec 2013
- News
To Market, to Market
Inhibitors of proteins that play an important role in cholesterol and fat metabolism, to be developed as potential therapeutics for the treatment of diseases such as metabolic syndrome, type 2 diabetes, coronary artery disease, and some... View Details
- Web
Krisha Patel | MBA
leverage my clinical and technical experience to explore roles in healthcare management, biotech startups, and healthtech venture capital to optimize the role technology can play in health care delivery, diagnostics, and therapeutics for... View Details
- 03 Nov 2016
- News
17 Ventures Join the Pagliuca Harvard Life Lab
Institute/HMS Nix – HBS, SEAS, Blavatnik Fellow PathoVax – HMS Piper Therapeutics – College, HBS Riparian Pharmaceuticals – College, SEAS Suono Bio – HMS UnNamed – HMS UrSure Inc. – HKS Vaxess Technologies, Inc. HBS, SEAS, HKS, HLS... View Details
- 20 Jun 2019
- Blog Post
What is the MS/MBA Biotechnology: Life Sciences Program? A Q&A with Bill Anderson, Senior Lecturer on Stem Cell and Regenerative Biology
Why is Harvard launching this program now? The advances in biotechnology over the past decade have been astounding. These new innovations have led to new therapeutics that will involve social, business, and political implications.... View Details
- 24 Apr 2019
- Blog Post
2019 New Venture Competition Student and Alumni Journeys
Business School’s Rock Center for Entrepreneurship and Alumni Clubs & Associations. The competition is open to alumni with early-stage ventures.Grand prize: Blueland Runner up: X-COR Therapeutics Crowd favorite: Blueland View Video View Details
- 01 Dec 2004
- News
The Future of Stem Cells
cardiovascular disease. In addition, apart from any possible therapeutic benefits, embryonic stem-cell research could play a central role in helping to understand the nature and development of disease generally. Spar, the Spangler Family... View Details
Keywords: Garry Emmons
- 01 Dec 2013
- News
Innovation as Antidote
inspiration typically comes from a very human place. DART Therapeutics CEO Gene Williams (MBA 1987) ("Your Own Medicine"), for instance, told us about a revelation he had during a 2002 trip to Rotterdam to observe clinical trials for the... View Details
Keywords: Health, Social Assistance
- 22 Mar 2022
- News
Clubs Mark a Milestone and the Lunar New Year
these virtual events included Moderna Therapeutics CEO Stefan Bancel (MBA 2000), JPMorgan Chase CEO Jamie Dimon (MBA 1982), and the president and CEO of Amazon, Andy Jassy (MBA 1997). “We’ve all worked together to be able to provide... View Details
Keywords: Margie Kelley
- 01 Mar 2017
- News
How Deep Brain Stimulation Could Change Medicine
communicating appropriately to maximize the therapeutic effects. The electrodes are placed inside the brain at the precise spot where the issue originates and communicate to a wireless monitor that tracks the neurotransmitter changes to... View Details
Keywords: Janelle Nanos